Intellia Therapeutics, Inc.NTLANASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, above historical average, structural decline.
Left:
||||
Year-over-year earnings per share growth rate
Latest
3.14%
↑ 114% above average
Average (9y)
-21.90%
Historical baseline
Range
High:49.64%
Low:-106.59%
CAGR
-26.4%
Structural decline
| Period | Value |
|---|---|
| 2024 | 3.14% |
| 2023 | 12.01% |
| 2022 | -62.96% |
| 2021 | -57.50% |
| 2020 | -22.45% |
| 2019 | 1.01% |
| 2018 | -5.32% |
| 2017 | -106.59% |
| 2016 | -30.00% |
| 2015 | 49.64% |